Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
814 дней спустя
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1080 дней спустя
Australian Dollar Rises Against Majors
The Australian dollar strengthened against other major currencies in the Asian session on Thursday.
RTTNews
|
1ч 16мин назад
European Economic News Preview: UK GDP Data Due
Quarterly national accounts from the UK and industrial production from the euro area are the major reports due on Thursday. At 2.00 am ET, the Office for National Statistics releases UK GDP, industrial production and foreign trade data. The economy is forecast to grow 0.2 percent sequentially, slower than the 0.3 percent expansion in the second quarter.
RTTNews
|
1ч 24мин назад
Australian Market Extends Early Losses In Mid-market
The Australian market is sharply extending its early losses in mid-market moves on Thursday, adding to the losses in the previous two sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,750 level, with weakness is financial, energy and technology stocks partially offset by gains in gold miner stocks.
RTTNews
|
3ч 9мин назад
Asian Markets Mixed Amid Cautious Trades
Asian markets are mixed on Thursday, following the mixed cues from Wall Street overnight, as traders remain cautious ahead of the release of a barrage of US economic data after the US House of Representatives voted on a bill to end the longest government shutdown in U.S. history. The end to the impasse would enable the US Fed to gauge the economy precisely well ahead of its December meeting.
RTTNews
|
3ч 14мин назад
Higher Open Called For Thai Stock Market
The Thai stock market has finished lower in consecutive trading days, dropping more than 20 points or 1.6 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,285-point plateau although it's expected to find traction on Thursday.
RTTNews
|
4ч 46мин назад
Japanese Market Notably Higher
The Japanese market is notably higher on Thursday, extending the gains in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is moving above the 51,250 level, with gains across most sectors led by technology and financial stocks. Index heavyweights were weak.
RTTNews
|
5ч 3мин назад
